U.S. flag

An official website of the United States government

NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.

Pollock K, Wilson E, Caswell G, et al. Family and health-care professionals managing medicines for patients with serious and terminal illness at home: a qualitative study. Southampton (UK): NIHR Journals Library; 2021 Aug. (Health Services and Delivery Research, No. 9.14.)

Cover of Family and health-care professionals managing medicines for patients with serious and terminal illness at home: a qualitative study

Family and health-care professionals managing medicines for patients with serious and terminal illness at home: a qualitative study.

Show details

Appendix 2Frequency of prescribed medication by case

Medications are listed by frequency of prescription, rather than alphabetically, to illustrate which classifications of medications were most frequently prescribed. The table includes both brand and generic names for medications, as reported by participants and their record reviews. Some cases had more than one drug prescribed from the same group.

Medicine classificationNumber of cases in which these medicines were prescribed
Opioid analgesics18
Proton pump inhibitors/H2-receptor antagonists11
Diuretics10
Antibacterials, antifungals9
Benzodiazepines8
Corticosteroid inhalers (with beta2 agonists)8
Antiplatelets7
Statins7
Non-opioid analgesics7
Calcium and vitamin D analogues6
Beta2 agonists6
Emollient creams and ointments6
Nitrates6
Angiotensin I/II receptor antagonists; ACE inhibitors6
Anticholinergics/antimuscarinics6
Antiepileptics6
Mucolytics6
Laxatives5
Tricyclic/tetracyclic antidepressants5
Antipsychotics5
Corticosteroids5
Selective serotonin re-uptake inhibitors5
Alpha-adrenoceptor blockers4
Beta-adrenoceptor blocker3
Biguanides3
Cardiac glycosides3
Factor Xa inhibitors3
Neuroprotectives3
Non-steroidal anti-inflammatory drugs3
Antihistamines2
Antimalarials2
Antispasmodics2
Aromatase inhibitors2
Bisphosphonates2
Calcium channel blockers2
Corticosteroid creams2
Dopamine receptor agonists2
Gliptin2
Iron, oral2
Non-benzodiazepine hypnotics and sedatives2
Non-sedating antihistamines2
Ocular lubricants2
Oxygen2
Penicillin2
Serotonin (5-HT3) receptor antagonists2
Sulfonylureas2
Vitamin K antagonists2
Xanthine oxidase inhibitors1
5α-reductase inhibitors1
Anaesthetics, local1
Antiandrogens1
Antimetabolites1
Antipropulsives1
Antiseptic mouthwash1
Antivertigo preparation1
Corticosteroid nasal spray1
Dopamine precursors1
Gonadotropin-releasing hormones1
Heparin1
Hyperpolarisation-activated cyclic nucleotide-gated channel blockers1
Immunosuppressants1
Muscle relaxants1
Nebuliser1
Non-invasive ventilation1
Oral rehydration salts1
Pancreatin1
Somatostatin analogues1
Thyroid hormone1
Bone resorption inhibitors1

ACE, angiotensin-converting enzyme.

Copyright © 2021 Pollock et al. This work was produced by Pollock et al. under the terms of a commissioning contract issued by the Secretary of State for Health and Social Care. This is an Open Access publication distributed under the terms of the Creative Commons Attribution CC BY 4.0 licence, which permits unrestricted use, distribution, reproduction and adaption in any medium and for any purpose provided that it is properly attributed. See: https://creativecommons.org/licenses/by/4.0/. For attribution the title, original author(s), the publication source – NIHR Journals Library, and the DOI of the publication must be cited.
Bookshelf ID: NBK573000

Views

  • PubReader
  • Print View
  • Cite this Page
  • PDF version of this title (80M)

Other titles in this collection

Recent Activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...